Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105418502B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105418502B details a novel rare earth catalyzed route for high-purity Paroxetine intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.